Novo Nordisk Keeps Rising as Analyst Upgrades Continue
(PLX AI) – Novo Nordisk shares rose another 1.3% today as analysts continued to lift their price targets after the third-quarter earnings.Momentum will continue into 2022 despite a potential negative impact from a Chinese drug pricing reform, SEB …
Weiterlesen »